Vesper Bio ApS: Financial statements 2012
CVR: 32879861
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -21,599 and a net result of DKK -16,199. Equity in the 2012 report amounted to DKK 376,837. The solvency ratio was 99.2%.
- Gross Profit
- DKK -21,599
- Profit/Loss
- DKK -16,199
- Equity
- DKK 376,837
- Total Assets
- DKK 379,836
Official annual report
Keep an eye on Vesper Bio ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of January 1, 2012, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Vesper Bio ApS.
As of January 1, 2012, REVISIONSFIRMA SVENDSEN & SØRENSEN I/S has stepped down as auditor of Vesper Bio ApS.
About Vesper Bio ApS
Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity in the 2025 report amounted to DKK -227,433,239.